ACM

ADAR1 Capital Management Portfolio holdings

AUM $1.34B
1-Year Est. Return 288.83%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+288.83%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.34B
AUM Growth
+$327M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
284
New
Increased
Reduced
Closed

Top Buys

1
+$31.8M
2
+$14.2M
3
+$12.6M
4
TERN icon
Terns Pharmaceuticals
TERN
+$12.3M
5
ABUS icon
Arbutus Biopharma
ABUS
+$11.3M

Top Sells

1
+$94.2M
2
+$31.1M
3
+$15.5M
4
MTSR
Metsera Inc
MTSR
+$7.98M
5
IVVD icon
Invivyd
IVVD
+$7.22M

Sector Composition

1 Healthcare 90.32%
2 Financials 1.75%
3 Real Estate 0.13%
4 Communication Services 0.08%
5 Consumer Discretionary 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASPC
251
A SPAC III Acquisition Corp
ASPC
$27.8M
– –
-215,000
ALMS
252
Alumis Inc
ALMS
$3.71B
– –
-61,291
LENZ
253
LENZ Therapeutics
LENZ
$428M
– –
-11,619
STI icon
254
Solidion Technology
STI
$32.7M
– –
0
GUTS icon
255
Fractyl Health
GUTS
$77M
– –
-13,097
XBI icon
256
State Street SPDR S&P Biotech ETF
XBI
$8.28B
– –
0
WVE icon
257
Wave Life Sciences
WVE
$2.57B
– –
-119,067
VRNA
258
DELISTED
Verona Pharma
VRNA
– –
-51,450
SAVA icon
259
Cassava Sciences
SAVA
$112M
– –
-81,000
RARE icon
260
Ultragenyx Pharmaceutical
RARE
$2.22B
– –
-9,000
PHGE icon
261
BiomX
PHGE
$6.8M
– –
-4,087
OTLK icon
262
Outlook Therapeutics
OTLK
$31M
– –
0
NERV icon
263
Minerva Neurosciences
NERV
$299M
– –
-12,406
MURA
264
DELISTED
Mural Oncology
MURA
– –
-11,855
MRUS
265
DELISTED
Merus
MRUS
– –
-33,313
MLTX icon
266
MoonLake Immunotherapeutics
MLTX
$1.25B
– –
-151,495
LQDA icon
267
Liquidia Corp
LQDA
$2.69B
– –
0
CYPH
268
Cypherpunk Technologies Inc
CYPH
$36.9M
– –
-25,830
LLY icon
269
Eli Lilly
LLY
$960B
– –
-1,000
KVAC icon
270
Keen Vision Acquisition Corp
KVAC
$110M
– –
0
KRRO icon
271
Korro Bio
KRRO
$108M
– –
-40,235
IOVA icon
272
Iovance Biotherapeutics
IOVA
$1.5B
– –
0
INBS icon
273
Intelligent Bio Solutions
INBS
$7.15M
– –
-42,643
IFRX icon
274
InflaRx
IFRX
$62.3M
– –
-159,479
HRMY icon
275
Harmony Biosciences
HRMY
$1.66B
– –
-10,245
8 9 10
11
12